Listed by the USPTO as SINGH, SATYENDRA K
Tech Center 1600 • Art Units: 1611 1653 1657
This examiner grants 62% of resolved cases
SINGH, SATYENDRA K works in Tech Center 1600 and art unit 1611. The profile covers 671 resolved cases, with an allowance rate of 61.5%. Interview activity shows a 67.9% lift, which exceeds the allowance rate and makes interview preparation a notable part of a prosecution plan. The median time to allowance is 1267 days, so applicants may benefit from addressing substantive issues without relying only on serial written amendments.
The listed companies are Armata Pharmaceuticals, Inc., Quest Diagnostics Investments Incorporated, and The University of North Carolina at Chapel Hill. The listed firms are NIXON & VANDERHYE, PC, SALIWANCHIK, LLOYD & EISENSCHENK, and Troutman Pepper Locke LLP. These names provide a useful reference set for matters prosecuted in the same examination environment.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18322823 | D-beta-HYDROXYBUTYRATE DEHYDROGENASES (BHBDhs) AND THEIR USE FOR KETONE MONITORING | Non-Final OA | The University of North Carolina at Chapel Hill |
| 18977262 | CONTROLLED OUTGASSING OF HYPERBARICALLY LOADED MATERIALS FOR THE DELIVERY OF OXYGEN AND OTHER THERAPEUTIC GASES IN BIOMEDICAL APPLICATIONS | Non-Final OA | The Johns Hopkins University |
| 17761594 | COMPOSITIONS AND METHODS FOR MICROBIOME MODULATION | Final Rejection | Washington University |
| 17924963 | COMPOSITIONS AND METHODS FOR INDUCING IMMUNE RESPONSES AGAINST CLASS I FUSION PROTEIN VIRUSES | Final Rejection | Virginia Tech Intellectual Properties, Inc. |
| 18973575 | NEW SIALYLTRANSFERASES FOR IN VIVO SYNTHESIS OF 3'SL | Non-Final OA | DSM IP Assets B.V. |
| 18339183 | MESOPOROUS SILICA BINDING PEPTIDES AND METHODS OF ENZYME IMMOBILIZATION USING THE SAME | Final Rejection | ARCHER DANIELS MIDLAND COMPANY |
| 18569377 | ENZYME AGENT CONTAINING TRANSGLUTAMINASE AND USE THEREOF | Non-Final OA | AMANO ENZYME INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy61.5% of resolved applications examined by Satyendra K Singh were allowed (671 resolved cases), compared with 35.0% across Art Unit 1611 over the last five years.
This examiner's interview lift is +67.9 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Satyendra K Singh took 1,267 days on average from filing to allowance.
Satyendra K Singh examines applications in Art Unit 1611 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
